Link Between Obstructive Sleep Apnea and Increased Bone Resorption in Men

Overview

Journal Osteoporos Int

Specialties Endocrinology
Orthopedics

Date 2008 Jan 29

PMID 18224268

Citations 39

Authors

H Tomiyama

R Okazaki

D Inoue

H Ochiai

K Shiina

Y Takata

H Hashimoto

A Yamashina

Affiliations

Soon will be listed here.

Abstract

Unlabelled: The bone metabolic abnormalities in patients with obstructive sleep apnea (OSA) were examined. Severity-dependent increases in the serum/urinary levels of bone resorption markers and their attenuation following continuous positive airway pressure therapy in subjects with OSA provide the first evidence of a link between OSA and abnormal bone metabolism.

Introduction: Hypoxia, microinflammation and oxidative stress, well-known pathophysiological features of obstructive sleep apnea (OSA), are also known to affect bone metabolism. We examined the bone metabolic abnormalities in patients with OSA and also the effects of continuous positive airway pressure (CPAP) therapy on these abnormalities.

Methods: A cross-sectional and prospective study was conducted in 50 consecutive male subjects visiting a sleep clinic and 15 age-matched control subjects without OSA. Plasma concentrations of IL-1beta, IL-6, TNF-alfa, 3-nitrotyrosine, osteocalcin, bone-specific alkaline phosphatase (BAP), and urinary concentrations of cross-linked C-terminal telopeptide of type I collagen (CTX) were examined before and after 3 months' CPAP in subjects with OSA.

Results: The plasma levels of the cytokines as well as the urinary CTX levels were higher in subjects with severe OSA than in those with mild OSA or control subjects. Significant decrease of the urinary excretion of CTX (before: 211+/-107 vs. after: 128+/-59 microg/mmol/creatinine; p<0.01) as well as of the plasma levels of the cytokines was observed following 3 months' CPAP.

Conclusions: Severity-dependent increases in the serum/urinary levels of bone resorption markers and their reversal following CPAP in subjects with OSA provide the first evidence of a link between OSA and abnormal bone metabolism.

Citing Articles

Association of Tumor Necrosis Factor-Alpha, Interleukin-1β, Interleukin-8, and Interferon-γ with Obstructive Sleep Apnea in Both Children and Adults: A Meta-Analysis of 102 Articles.

Golshah A, Sadeghi E, Sadeghi M J Clin Med. 2024; 13(5).

PMID: 38592305 PMC: 10932105. DOI: 10.3390/jcm13051484.

Association between obstructive sleep apnea and low bone mass in adults: a systematic review and meta-analysis.

Wang X, Wang X, Liao Z, Zhao Y, Wei C, Gong L Sleep Biol Rhythms. 2024; 22(1):65-73.

PMID: 38476856 PMC: 10899924. DOI: 10.1007/s41105-023-00481-1.

Early bone loss in patients with obstructive sleep apnea: a cross-sectional study.

Qiao Y, Guo J, Luo J, Huang R, Wang X, Su L BMC Pulm Med. 2024; 24(1):28.

PMID: 38200497 PMC: 10782667. DOI: 10.1186/s12890-024-02848-7.

Continuous positive airway pressure treatment improves bone mineral density in men affected by severe obstructive sleep apnea syndrome.

Carpi M, Cordella A, Placidi F, Izzi F, Piccirilli E, Mercuri N J Clin Sleep Med. 2023; 20(1):67-73.

PMID: 37677073 PMC: 10758556. DOI: 10.5664/jcsm.10796.

Association of Self-Reported Sleep Characteristics and Hip Fracture: Observational and Mendelian Randomization Studies.

Wang Y, Luo Y, Mhalgi A, Ren W, Wu L Healthcare (Basel). 2023; 11(7).

PMID: 37046853 PMC: 10094697. DOI: 10.3390/healthcare11070926.

References

Boyle W, Simonet W, Lacey D . Osteoclast differentiation and activation. Nature. 2003; 423(6937):337-42. DOI: 10.1038/nature01658. View

Marin J, Carrizo S, Vicente E, Agusti A . Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005; 365(9464):1046-53. DOI: 10.1016/S0140-6736(05)71141-7. View

Clowes J, Riggs B, Khosla S . The role of the immune system in the pathophysiology of osteoporosis. Immunol Rev. 2005; 208:207-27. DOI: 10.1111/j.0105-2896.2005.00334.x. View

Fulkerson J, Himes J, French S, Jensen S, Petit M, Stewart C . Bone outcomes and technical measurement issues of bone health among children and adolescents: considerations for nutrition and physical activity intervention trials. Osteoporos Int. 2004; 15(12):929-41. DOI: 10.1007/s00198-004-1685-3. View

Manelli F, Giustina A . Glucocorticoid-induced osteoporosis. Trends Endocrinol Metab. 2000; 11(3):79-85. DOI: 10.1016/s1043-2760(00)00234-4. View

De La Pena Bravo M, Serpero L, Barcelo A, Barbe F, Agusti A, Gozal D . Inflammatory proteins in patients with obstructive sleep apnea with and without daytime sleepiness. Sleep Breath. 2007; 11(3):177-85. DOI: 10.1007/s11325-007-0100-7. View

Vgontzas A, Pejovic S, Zoumakis E, Lin H, Bentley C, Bixler E . Hypothalamic-pituitary-adrenal axis activity in obese men with and without sleep apnea: effects of continuous positive airway pressure therapy. J Clin Endocrinol Metab. 2007; 92(11):4199-207. DOI: 10.1210/jc.2007-0774. View

. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep. 1999; 22(5):667-89. View

Sun Y, Chang P, Tsao K, Wu T, Sun C, Wu L . Establishment of a sandwich ELISA using commercial antibody for plasma or serum 3-nitrotyrosine (3NT). Elevation in inflammatory diseases and complementary between 3NT and myeloperoxidase. Clin Chim Acta. 2006; 378(1-2):175-80. DOI: 10.1016/j.cca.2006.11.014. View

10.

Basu S, Michaelsson K, Olofsson H, Johansson S, Melhus H . Association between oxidative stress and bone mineral density. Biochem Biophys Res Commun. 2001; 288(1):275-9. DOI: 10.1006/bbrc.2001.5747. View

11.

Shiina K, Tomiyama H, Takata Y, Usui Y, Asano K, Hirayama Y . Concurrent presence of metabolic syndrome in obstructive sleep apnea syndrome exacerbates the cardiovascular risk: a sleep clinic cohort study. Hypertens Res. 2006; 29(6):433-41. DOI: 10.1291/hypres.29.433. View

12.

Utting J, Robins S, Brandao-Burch A, Orriss I, Behar J, Arnett T . Hypoxia inhibits the growth, differentiation and bone-forming capacity of rat osteoblasts. Exp Cell Res. 2006; 312(10):1693-702. DOI: 10.1016/j.yexcr.2006.02.007. View

13.

Hatipoglu U, Rubinstein I . Inflammation and obstructive sleep apnea syndrome pathogenesis: a working hypothesis. Respiration. 2004; 70(6):665-71. DOI: 10.1159/000075218. View

14.

Rogers A, Eastell R . Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment. J Clin Endocrinol Metab. 2005; 90(11):6323-31. DOI: 10.1210/jc.2005-0794. View

15.

Shamsuzzaman A, Gersh B, Somers V . Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA. 2003; 290(14):1906-14. DOI: 10.1001/jama.290.14.1906. View

16.

Tomlinson J, Bujalska I, Stewart P, Cooper M . The role of 11 beta-hydroxysteroid dehydrogenase in central obesity and osteoporosis. Endocr Res. 2001; 26(4):711-22. DOI: 10.3109/07435800009048591. View

17.

Sambrook P, Cooper C . Osteoporosis. Lancet. 2006; 367(9527):2010-8. DOI: 10.1016/S0140-6736(06)68891-0. View

18.

Arnett T, Gibbons D, Utting J, Orriss I, Hoebertz A, Rosendaal M . Hypoxia is a major stimulator of osteoclast formation and bone resorption. J Cell Physiol. 2003; 196(1):2-8. DOI: 10.1002/jcp.10321. View

19.

Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G . Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation. 2003; 107(8):1129-34. DOI: 10.1161/01.cir.0000052627.99976.18. View

20.

Caples S, Gami A, Somers V . Obstructive sleep apnea. Ann Intern Med. 2005; 142(3):187-97. DOI: 10.7326/0003-4819-142-3-200502010-00010. View